Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD
James M. Paik, Pegah Golabi, Youssef Younossi, Alita Mishra, Zobair M. Younossi – 11 February 2020
Letter to the Editor: Quantitative Histological Assessment in Nonalcoholic Fatty Liver Disease
Samer Gawrieh, David E. Kleiner, Naga Chalasani, Scott Vanderbeck – 11 February 2020
Masthead
10 February 2020
Instructions to Authors
10 February 2020
Hepatology Highlights
Alyson Kaplan, Russell Rosenblatt, Nicholas W. Russo, Robert S. Brown, Joseph F. Pisa, Petra Hirsova, Robert E. Schwartz, Enis Kostallari, Nidhi Jalan‐Sakrikar, Rajab Idriss, Hirsh Trivedi, Daryl T.Y. Lau, Amaia Navarro‐Corcuera – 10 February 2020
Notices
10 February 2020
NAFLD‐Related Hepatocellular Carcinoma and the Four Horsemen of the Apocalypse
Jose D. Debes, Andre Boonstra, Robert J. Knegt – 10 February 2020
Table of contents
10 February 2020
Cover Image
10 February 2020
Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes
Michael J. Weaver, Scott A. McHenry, Gregory S. Sayuk, C. Prakash Gyawali, Nicholas O. Davidson – 9 February 2020 – Irritable bowel syndrome with diarrhea (IBS‐D) and NAFLD are both common conditions that may be influenced by shared pathways of altered bile acid (BA) signaling and homeostatic regulation.